Preoperative sedation with intravenous S-ketamine versus midazolam in preschool children: a randomized controlled

Yu-Qi Liao1, Jun Ma2, Yi He2

  • 1Department of Anesthesiology, The Third People's Hospital of Chengdu, Chengdu, Sichuan, 610031, China.

BMC Anesthesiology
|November 22, 2025
PubMed

Insights

S-ketamine (0.5 mg/kg) provided deeper sedation than midazolam (0.08 mg/kg) for preschool children undergoing anesthesia. While effective for preoperative anxiety, S-ketamine slightly increased emergence time.

Area of Science:

  • Anesthesiology
  • Pediatric Medicine
  • Pharmacology

Background:

  • Preoperative anxiety in children can lead to difficult parent-child separation and anesthesia induction challenges.
  • Effective preoperative sedation is crucial for managing anxiety in preschool-aged children.
  • This study addresses the need for optimal sedation strategies in pediatric anesthesia.

Purpose of the Study:

  • To compare the efficacy of S-ketamine versus midazolam for preoperative sedation in children aged 2-6 years.
  • To evaluate sedative effects, parent separation anxiety, postoperative agitation, satisfaction, and mask compliance.

Main Methods:

  • A prospective randomized controlled trial involving 104 children aged 2-6 years.
  • Children were assigned to receive either S-ketamine (0.5 mg/kg) or midazolam (0.08 mg/kg) intravenously.
  • The Modified Yale Preoperative Anxiety Scale (mYPAS) was the primary outcome measure.

Main Results:

  • Both S-ketamine and midazolam effectively controlled preoperative stress.
  • S-ketamine resulted in significantly lower mYPAS scores compared to midazolam (P=0.025).
  • A longer emergence time was observed with S-ketamine (P=0.036), with no significant differences in other secondary outcomes.

Conclusions:

  • A single intravenous dose of S-ketamine (0.5 mg/kg) offers superior sedative effects compared to midazolam (0.08 mg/kg) in pediatric patients.
  • S-ketamine is an effective option for managing preoperative anxiety in children, despite a potential for slightly prolonged emergence.
  • The findings support S-ketamine as a valuable alternative for preoperative sedation in pediatric anesthesia.
Abstract

Related Concept Videos

Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
2.6K
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
1.0K
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
1.7K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410